Busulfan, fludarabine, and alemtuzumab conditioning and unrelated cord blood transplantation in children with sickle cell disease.

Radhakrishnan K; Bhatia M; Geyer MB; Del Toro G; Jin Z; Baker C; Harrison L; Morris E; Baxter-Lowe LA; Cairo MS

doi:10.1016/j.bbmt.2013.02.002

Busulfan, fludarabine, and alemtuzumab conditioning and unrelated cord blood transplantation in children with sickle cell disease.

Identifier:nobleid.org/w1/20260526/C40BADF6

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C40BADF6.svg?ark=w1%2F20260526%2FC40BADF6)](https://nobleid.org/work/w1/20260526/C40BADF6)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Busulfan, fludarabine, and alemtuzumab conditioning and unrelated cord blood transplantation in children with sickle cell disease.

Identifier:nobleid.org/w1/20260526/C40BADF6

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C40BADF6.svg?ark=w1%2F20260526%2FC40BADF6)](https://nobleid.org/work/w1/20260526/C40BADF6)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work